Literature DB >> 18814264

Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells.

Weiyun Z Ai1, Jing-Zhou Hou, Robert Zeiser, Debra Czerwinski, Robert S Negrin, Ronald Levy.   

Abstract

There has been accumulating evidence that CD4(+)CD25(+) FoxP3 expressing regulatory T cells (Treg) are highly concentrated in tumors, thereby fostering an immune-privileged microenvironment. Some studies have shown that T-cell receptor (TCR) stimulation can convert conventional T cells into Treg. Follicular lymphoma (FL) B cells can enhance this Treg conversion. We investigated whether FL tumor B cells, as opposed to normal B cells, are unique in their ability to convert effector T cells into Treg. We found that tumor B cells alone, without artificial TCR stimulation, could induce conventional T cells to express FoxP3 and to acquire regulatory function. In contrast to their malignant counterpart, normal B cells did not induce Treg conversion. Treg conversion was independent of the T cell background, as T cells isolated from FL or normal peripheral blood were equally susceptible to being converted by tumor B cells. Our study provides evidence for a tumor-specific mechanism by which FL tumor cells promote immune escape through the induction of Treg.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18814264      PMCID: PMC2631275          DOI: 10.1002/ijc.23881

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  41 in total

1.  Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.

Authors:  James R Cerhan; Sophia Wang; Matthew J Maurer; Stephen M Ansell; Susan M Geyer; Wendy Cozen; Lindsay M Morton; Scott Davis; Richard K Severson; Nathaniel Rothman; Charles F Lynch; Sholom Wacholder; Stephen J Chanock; Thomas M Habermann; Patricia Hartge
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

2.  Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

Authors:  Annuska M Glas; Laurent Knoops; Leonie Delahaye; Marie José Kersten; Robby E Kibbelaar; Lodewyk A Wessels; Ryan van Laar; J Han J M van Krieken; Joke W Baars; John Raemaekers; Philip M Kluin; Laura J van't Veer; Daphne de Jong
Journal:  J Clin Oncol       Date:  2007-01-02       Impact factor: 44.544

3.  In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma.

Authors:  Marc Beyer; Matthias Kochanek; Thomas Giese; Elmar Endl; Martin R Weihrauch; Percy A Knolle; Sabine Classen; Joachim L Schultze
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

4.  Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells.

Authors:  Hyung W Lim; Hal E Broxmeyer; Chang H Kim
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

5.  Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.

Authors:  Zhi-Zhang Yang; Anne J Novak; Steven C Ziesmer; Thomas E Witzig; Stephen M Ansell
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

6.  Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.

Authors:  Shannon P Hilchey; Asit De; Lisa M Rimsza; Richard B Bankert; Steven H Bernstein
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

7.  Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.

Authors:  Jun Wang; Andreea Ioan-Facsinay; Ellen I H van der Voort; Tom W J Huizinga; René E M Toes
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

8.  Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens.

Authors:  Denise Golgher; Emma Jones; Fiona Powrie; Tim Elliott; Awen Gallimore
Journal:  Eur J Immunol       Date:  2002-11       Impact factor: 5.532

9.  CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells.

Authors:  Zhi-Zhang Yang; Anne J Novak; Steven C Ziesmer; Thomas E Witzig; Stephen M Ansell
Journal:  Blood       Date:  2007-07-05       Impact factor: 22.113

10.  Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.

Authors:  Tomoki Ito; Maria Yang; Yui-Hsi Wang; Roberto Lande; Josh Gregorio; Olivia A Perng; Xiao-Feng Qin; Yong-Jun Liu; Michel Gilliet
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

View more
  29 in total

1.  Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence.

Authors:  Shawn M Jensen; Christopher G Twitty; Levi D Maston; Paul A Antony; May Lim; Hong-Ming Hu; Ulf Petrausch; Nicholas P Restifo; Bernard A Fox
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

2.  Clinicobiological, prognostic and therapeutic implications of the tumor microenvironment in follicular lymphoma.

Authors:  Marylène Lejeune; Tomás Alvaro
Journal:  Haematologica       Date:  2009-01       Impact factor: 9.941

Review 3.  The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Authors:  K H Shain; W S Dalton; J Tao
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

Review 4.  Pathogenesis of follicular lymphoma.

Authors:  Robert Kridel; Laurie H Sehn; Randy D Gascoyne
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

Review 5.  T regulatory cells in B-cell malignancy - tumour support or kiss of death?

Authors:  Camilla A Lindqvist; Angelica S I Loskog
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

6.  Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics.

Authors:  S Donnou; C Galand; C Daussy; L Crozet; W H Fridman; C Sautès-Fridman; S Fisson
Journal:  Clin Exp Immunol       Date:  2011-06-10       Impact factor: 4.330

7.  Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.

Authors:  Kui Shin Voo; Myriam Foglietta; Elena Percivalle; Fuliang Chu; Durga Nattamai; Megan Harline; Seung-Tae Lee; Laura Bover; Heather Y Lin; Veerabhadran Baladandayuthapani; David Delgado; Amber Luong; R Eric Davis; Larry W Kwak; Yong-Jun Liu; Sattva S Neelapu
Journal:  Int J Cancer       Date:  2014-05-12       Impact factor: 7.396

8.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-03       Impact factor: 0.196

9.  Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy.

Authors:  Alan G Ramsay; Andrew J Clear; Gavin Kelly; Rewas Fatah; Janet Matthews; Finlay Macdougall; T Andrew Lister; Abigail M Lee; Maria Calaminici; John G Gribben
Journal:  Blood       Date:  2009-09-28       Impact factor: 22.113

10.  Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.

Authors:  Seema Rawal; Fuliang Chu; Min Zhang; Hyun Jun Park; Durga Nattamai; Shibichakravarthy Kannan; Rakesh Sharma; David Delgado; Tina Chou; Heather Y Lin; Veerabhadran Baladandayuthapani; Amber Luong; Francisco Vega; Nathan Fowler; Chen Dong; R Eric Davis; Sattva S Neelapu
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.